Skip to content

Unlock the Power of Phenotypic Screening

Revolutionize Drug Discovery with Advanced Machine Learning

shipped Nov 21, 2025verticalspaid
Read full review
Visit Recursion OS
VerticalsLife SciencesDrug Discovery
Recursion OS - AI tool hero image
1Accelerate the drug discovery process with cutting-edge ML capabilities.
2Transform complex biological data into actionable insights seamlessly.
3Enhance accuracy and efficiency in phenotypic screening.

Stork Quadrant

Sleeping Giant· 33/100

Has a real moat but invisible to agents. Add an MCP and you'd climb.

Recursion's defensibility is high because the core moat is proprietary phenotypic data accumulated from years of wet-lab screening, plus the physical infrastructure (robotics, imaging hardware, cell lines) required to generate it. An LLM can interpret images or suggest experiments, but cannot replace the biological ground truth Recursion owns. The regulatory pathway (FDA, pharma partnerships) and liability for drug discovery decisions add trust moats. This is not a software-only tool — it's a biotech platform.

Claude Haiku 4.5, scored 2026-05-26

Defensibility · 60/100

  • Physical-world coupling
  • Regulatory moat
  • Network liquidity
  • Proprietary refreshing data
  • High-trust catastrophic workflows
  • Multi-party coordination
  • Brand / community / taste

An LLM alone could replace

  • Analyzing microscopy images to identify morphological patterns
  • Generating hypotheses about compound effects on cell phenotypes
  • Summarizing screening results into structured reports
  • Suggesting next-step experiments based on phenotypic data

Agent-Readiness · 0/100

  • Verified MCP
  • Listed on agent surfaces
  • Usage-based pricing
  • Headless agent auth
  • Public OpenAPI
  • Active changelog
  • llms.txt

How to defend

Keep the data moat alive by continuously screening novel compounds and cell models competitors can't access. Double down on being the discovery engine pharma companies license, not a generic image-analysis SaaS. Resist the urge to become a UI for LLM analysis — stay vertically integrated with the lab.

  • Ship an MCP server and list it on Stork — biggest single point gain (+25).
  • Get listed in the Anthropic MCP registry, Cursor, or Claude Desktop (+20).
  • Add a usage-based or per-call tier; per-seat-only pricing dies when agents replace seats (+15).
  • Expose API-key auth with a self-serve sandbox tier; remove sales-call gates (+15).
  • Publish an OpenAPI spec at /openapi.json or /.well-known/openapi (+10).

Similar Tools

Compare Alternatives

Other tools you might consider

1

Genesis Therapeutics AI Platform

Shares tags: verticals, life sciences, drug discovery

View on Stork
2

Benchling AI

Shares tags: verticals, life sciences, drug discovery

View on Stork
3

Insilico Medicine Pharma.AI

Shares tags: verticals, life sciences, drug discovery

View on Stork
4

Schrödinger AutoQSAR

Shares tags: verticals, life sciences, drug discovery

View on Stork

Connect

overview

What is Recursion OS?

Recursion OS is a state-of-the-art platform designed to streamline phenotypic screening by leveraging the power of machine learning. It enables researchers in the life sciences and drug discovery sectors to uncover insights faster and more efficiently than ever before.

  • 1Integrates seamlessly within existing workflows.
  • 2Designed for researchers by researchers.
  • 3Supports a wide range of drug discovery projects.

features

Key Features

Recursion OS comes equipped with a robust suite of features tailored for the life sciences domain. Its intelligent algorithms allow for the processing of vast datasets, delivering relevant results in real time.

  • 1Advanced ML algorithms tailored for phenotypic data.
  • 2Real-time data analysis and visualization.
  • 3Customizable workflows to meet specific research needs.

use cases

Real-World Applications

From pharmaceutical companies to academic institutions, Recursion OS is empowering a diverse range of users. It has consistently proven its value in identifying new pathways for drug development and enhancing existing screening processes.

  • 1Streamline hit identification in drug discovery.
  • 2Facilitate understanding of disease mechanisms.
  • 3Improve collaboration across research teams.

Frequently Asked Questions

+What industries can benefit from Recursion OS?

Recursion OS is primarily designed for the life sciences and drug discovery sectors, but its capabilities can extend to any field that requires deep biological data analysis.

+How does Recursion OS improve phenotypic screening?

By using advanced machine learning algorithms, Recursion OS enhances the accuracy, speed, and scalability of phenotypic screening, allowing researchers to make more informed decisions.

+Is training required to use Recursion OS?

While Recursion OS is designed to be user-friendly, we offer comprehensive training resources and support to ensure all users can maximize their experience with the platform.

For builders

This page is doing a job for someone else’s tool.

AI agents read it. Buyers find it. Backlinks accrue. Your tool can have one too — live in 24 hours, indexed by Claude, ChatGPT, and Perplexity, queryable via MCP.